Skip to main content
. 2021 Jul 16;7:181. doi: 10.1038/s41420-021-00571-4

Fig. 2. Effect of erlotinib on LPS-induced parthanatos.

Fig. 2

Macrophages collected from peritoneal lavage at 24 h after pretreated with erlotinib or 3-AB with LPS treatment. a, c Immunoblotted for PARP-1 activation, PAR formation, and GAPDH. b, d Mensuration of PARP-1 (b) and PAR (d) expressions. e Immunoblot analysis of AIF and Lamin B amount in nuclei. f Mensuration of AIF expression in nuclei. g Fluorescence images depicting AIF translocation (up panel; scale bar, 100 μm). Error bars represent SD (n = 3). *P < 0.05 as compared with NC; P < 0.05 as compared with LPS group.